Relevant bibliographies by topics / Human immunodeficiency virus / Journal articles

Journal articles on the topic 'Human immunodeficiency virus'

To see the other types of publications on this topic, follow the link: Human immunodeficiency virus.
Author: Grafiati
Published: 4 June 2021
Last updated: 6 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Human immunodeficiency virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lederman, Michael. "Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis." Thrombosis and Haemostasis 104, no. 11 (2010): 911–14. http://dx.doi.org/10.1160/th10-02-0096.

Full text
Abstract:
SummaryIn July 1982, the occurrence of three cases of acquired immunodeficiency syndrome (AIDS) in men with haemophilia was an immediate signal to Oscar Ratnoff that AIDS was transmissible through blood products. Work that he led provided important and clear indication that the AIDS agent was transmissible through pooled plasma products and had rapidly infected many men who had haemophilia. Before the blood supply was protected, the risk for infection in haemophilia was related directly to the intensity of therapy with pooled anti-haemophilic factor concentrates. Studies performed among the small proportion of haemophiliacs who remained uninfected despite heavy exposure to these plasma products revealed that the rare protective genotype – homozygosity for the 32 base pair deletion in the CCR5 gene was heavily concentrated in this population. Among those who did not have this protective genotype, a state of diminished immune activation distinguished these high risk uninfected haemophiliacs from haemophiliacs who later acquired human immunodeficiency virus (HIV) infection and from healthy uninfected controls. Immune activation state may not only predict risk for HIV acquisition but also appears to be an important predictor and likely determinant of HIV disease progression. The potential drivers of immune activation in chronic HIV infection include HIV itself, other co-infecting pathogens, homeostatic responses to cytopenia as well as the recently recognised phenomenon of translocation of microbial products across a damaged gut mucosal surface. This latter process is particularly compelling as clinical studies have shown a good relationship between indices of microbial translocation and markers of both immune activation and T cell homeostasis in chronic HIV infection. More recently, we have also found evidence that these microbial products also may drive a heightened tendency to thrombus formation in HIV infection via induction of monocyte tissue factor expression. Thus systemic exposure to microbial elements that are translocated through a gut mucosa damaged in the first few weeks of HIV infection may contribute to the pathogenesis of both immune deficiency and the heightened risk for vascular events that have been noted in persons with HIV infection.
APA, Harvard, Vancouver, ISO, and other styles
2

Tagawa, Miho. "4. Human Immunodeficiency Virus Associated Renal Dysfunction." Nihon Naika Gakkai Zasshi 100, no. 5 (2011): 1319–23. http://dx.doi.org/10.2169/naika.100.1319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kamal, K. "Human Immunodeficiency Virus." Pediatrics in Review 26, no. 2 (February 1, 2005): 67. http://dx.doi.org/10.1542/pir.26-2-67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Price, TW, SG DeMars, DL Palmer, MI Altman, and JW Moore. "Human immunodeficiency virus." Journal of the American Podiatric Medical Association 80, no. 9 (September 1, 1990): 510. http://dx.doi.org/10.7547/87507315-80-9-510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kamal, Khalid. "Human Immunodeficiency Virus." Pediatrics In Review 26, no. 2 (February 1, 2005): 67. http://dx.doi.org/10.1542/pir.26.2.67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Autran, Brigitte. "Human Immunodeficiency Virus." Expert Review of Vaccines 3, sup1 (August 2004): S3—S4. http://dx.doi.org/10.1586/14760584.3.4.s3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

DYKEMAN, MARGARET, KELLY FUGATE, and SARAH LAU. "Human Immunodeficiency Virus." Nurse Practitioner 22, no. 3 (March 1997): 94???104. http://dx.doi.org/10.1097/00006205-199703000-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brown, F. "Human immunodeficiency virus." Science 232, no. 4757 (June 20, 1986): 1486. http://dx.doi.org/10.1126/science.3012776.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Skinner, Anita. "Human immunodeficiency virus." Nursing Standard 31, no. 13 (November 23, 2016): 64–65. http://dx.doi.org/10.7748/ns.31.13.64.s46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Phillips, David M. "Human Immunodeficiency Virus." New England Journal of Medicine 332, no. 4 (January 26, 1995): 233. http://dx.doi.org/10.1056/nejm199501263320406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Isaacs, David, and John Ziegler. "HUMAN IMMUNODEFICIENCY VIRUS." Pediatric Infectious Disease Journal 12, no. 12 (December 1993): 1038. http://dx.doi.org/10.1097/00006454-199312000-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

RISI, GEORGE F., RICHARD H. GAUMER, STEVEN WEEKS, JEAN K. LEETE, and CHARLES V. SANDERS. "Human Immunodeficiency Virus." Southern Medical Journal 82, no. 9 (September 1989): 1079–82. http://dx.doi.org/10.1097/00007611-198909000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Maschera, Barbara, Graham Darby, Giorgio Palú, Lois L. Wright, Margaret Tisdale, Richard Myers, Edward D. Blair, and Eric S. Furfine. "Human Immunodeficiency Virus." Journal of Biological Chemistry 271, no. 52 (December 27, 1996): 33231–35. http://dx.doi.org/10.1074/jbc.271.52.33231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Weissberg, Dov. "Human immunodeficiency virus." Annals of Thoracic Surgery 48, no. 5 (November 1989): 745. http://dx.doi.org/10.1016/0003-4975(89)90821-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Gaiser, Robert. "Human Immunodeficiency Virus." Survey of Anesthesiology 48, no. 6 (December 2004): 292–93. http://dx.doi.org/10.1097/01.sa.0000144233.48390.52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Siripurapu, Rekha, and Yoshiaki Ota. "Human Immunodeficiency Virus." Neuroimaging Clinics of North America 33, no. 1 (February 2023): 147–65. http://dx.doi.org/10.1016/j.nic.2022.07.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Malani, Preeti N. "Human Immunodeficiency Virus." JAMA 316, no. 2 (July 12, 2016): 238. http://dx.doi.org/10.1001/jama.2016.7995.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kamphawi, Martha, and Seter Siziya. "Association between Human Immunodeficiency Virus and premature rupture of membranes." Asian Pacific Journal of Health Sciences 4, no. 3 (September 30, 2017): 235–38. http://dx.doi.org/10.21276/apjhs.2017.4.3.35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Pandey, Chandra Mani, and Jai Prakash. "Health Status of Orphan Children Infected with Human Immunodeficiency Virus." Pediatric Education and Research 5, no. 1 (2017): 13–16. http://dx.doi.org/10.21088/per.2321.1644.5117.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Patil, Arundhati, and Keerti Deep. "Profile of Children with Human Immunodeficiency Virus Infection: Descriptive Study." Indian Journal of Trauma and Emergency Pediatrics 8, no. 2 (2016): 67–70. http://dx.doi.org/10.21088/ijtep.2348.9987.8216.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Silva Júnior, Sergio Vital da, Wilton José de Carvalho Silva, Natalia Silva Lourenço, Jordana Almeida Nogueira, Ana Cristina de Oliveira e Silva, and Maria Eliane Moreira Freire. "Quality of life of people living with the human immunodeficiency virus and acquired immunodeficiency syndrome." Rev Rene 20 (May 9, 2019): e39638. http://dx.doi.org/10.15253/2175-6783.20192039638.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Straub, OC, and D. Lévy. "Bovine immunodeficiency virus and analogies with human immunodeficiency virus." Leukemia 13, S1 (April 1999): S106—S109. http://dx.doi.org/10.1038/sj.leu.2401324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Matsushita, Shuzo. "Human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) and intensive care unit." Journal of the Japanese Society of Intensive Care Medicine 14, no. 3 (2007): 260–62. http://dx.doi.org/10.3918/jsicm.14.260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Warner, Mark A., and Steve E. Kunkel. "Human Immunodeficiency Virus Infection." Anesthesiology Clinics of North America 7, no. 4 (December 1989): 795–811. http://dx.doi.org/10.1016/s0889-8537(21)00172-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Sinha, Nitin, Sahil Sareen, AshwiniKumar Malhotra, and Sanchit Singh. "Human immunodeficiency virus encephalitis." Indian Journal of Sexually Transmitted Diseases and AIDS 41, no. 1 (2020): 108. http://dx.doi.org/10.4103/ijstd.ijstd_112_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Lakshmanan, Priyanka, and Ira Shah. "Human immunodeficiency virus polyarthropathy." Journal of Family Medicine and Primary Care 5, no. 3 (2016): 725. http://dx.doi.org/10.4103/2249-4863.197289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Wheat, Santina, and Evan Wittke. "Human Immunodeficiency Virus Care." Primary Care: Clinics in Office Practice 48, no. 2 (June 2021): 311–28. http://dx.doi.org/10.1016/j.pop.2021.02.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

CASE, KATHLEEN. "Nomenclature: Human Immunodeficiency Virus." Annals of Internal Medicine 105, no. 1 (July 1, 1986): 133. http://dx.doi.org/10.7326/0003-4819-105-1-133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Hollander, Harry. "Human immunodeficiency virus infection." Postgraduate Medicine 81, no. 4 (March 1987): 79–84. http://dx.doi.org/10.1080/00325481.1987.11699742.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Sinha, Uma, Prasanta Mukhopadhyay, Nilanjan Sengupta, and KeshabSinha Roy. "Human immunodeficiency virus endocrinopathy." Indian Journal of Endocrinology and Metabolism 15, no. 4 (2011): 251. http://dx.doi.org/10.4103/2230-8210.85574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Volberding, Paul A., Kelty R. Baker, and Alexandra M. Levine. "Human Immunodeficiency Virus Hematology." Hematology 2003, no. 1 (January 1, 2003): 294–313. http://dx.doi.org/10.1182/asheducation-2003.1.294.

Full text
Abstract:
Abstract The advent of potent antiretroviral therapy has altered the expected natural history of human immunodeficiency virus (HIV) infection and of many previously associated opportunistic complications, including malignancies. At the same time, HIV suppression hasn’t affected all of these complications equally and the longer expected survival of infected patients may allow the development of newer complications. Additionally, the use of potent antiretroviral combination therapy may itself lead to hematological toxicities. Together these changes affect the consultation role of the hematology-oncology specialist in comprehensive HIV care and demand ongoing education. In Section I, Dr. Paul Volberding reviews the biology of antiretroviral drug development and the progression in discovering new agents as the viral life cycle is further elucidated. He briefly summarizes the process of combining agents to achieve the degree of viral suppression required for long-term clinical benefit. In Section II, Dr. Kelty Baker reviews the effects of HIV and its therapy on hematologic dyscrasia and clotting disorders. She summarizes how therapy may decrease certain previously common manifestations of HIV disease while adding new problems likely to result in referral to the hematologist. In addition, she addresses the role of secondary infections, such as parvovirus, in this spectrum of disorders. In Section III, Dr. Alexandra Levine discusses the still challenging aspects of HIV associated non-Hodgkin’s lymphoma and the association between HIV infection and Hodgkin’s disease. She addresses current controversies in the pathogenesis of HIV related lymphomas and summarizes a number of recent trials of combination chemotherapy, with or without monoclonal antibodies, in their management. Additionally, she reviews the complex relationship of HIV disease with multicentric Castleman’s disease and recent attempts to manage this disorder.
APA, Harvard, Vancouver, ISO, and other styles
32

Garland, Suzanne. "Human Immunodeficiency Virus (HIV)." Papillomavirus Report 15, no. 4 (July 2004): 229–32. http://dx.doi.org/10.1179/095741904225005133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Jones, Kimmith M. "Human Immunodeficiency Virus Disease." Critical Care Nursing Clinics of North America 11, no. 4 (December 1999): 455–64. http://dx.doi.org/10.1016/s0899-5885(18)30137-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Tramont, COL Edmund C. "The Human Immunodeficiency Virus." Dermatologic Clinics 9, no. 3 (July 1991): 397–401. http://dx.doi.org/10.1016/s0733-8635(18)30390-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Knobler, Robert M. "Human Immunodeficiency Virus Infection." Dermatologic Clinics 7, no. 2 (April 1989): 369–86. http://dx.doi.org/10.1016/s0733-8635(18)30606-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Darke, P. L., C. T. Leu, L. J. Davis, J. C. Heimbach, R. E. Diehl, W. S. Hill, R. A. Dixon, and I. S. Sigal. "Human immunodeficiency virus protease." Journal of Biological Chemistry 264, no. 4 (February 1989): 2307–12. http://dx.doi.org/10.1016/s0021-9258(18)94177-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

SMITH, MIKE U., ROZ E. GOUDEAU, HAROLD P. KATNER, and J. THEODORE FARMER. "Human Immunodeficiency Virus Infection." Southern Medical Journal 86, no. 5 (May 1993): 537–44. http://dx.doi.org/10.1097/00007611-199305000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Senturia, Y. D., and C. S. Peckham. "Neonatal human immunodeficiency virus." Current Opinion in Infectious Diseases 1, no. 3 (May 1988): 473–78. http://dx.doi.org/10.1097/00001432-198805000-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Hardy, William D. "THE HUMAN IMMUNODEFICIENCY VIRUS." Medical Clinics of North America 80, no. 6 (November 1996): 1239–61. http://dx.doi.org/10.1016/s0025-7125(05)70489-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Zurlo, John J. "The Human Immunodeficiency Virus." Otolaryngologic Clinics of North America 25, no. 6 (December 1992): 1159–81. http://dx.doi.org/10.1016/s0030-6665(20)30888-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Chermann, J. C. "Human Immunodeficiency Virus (HIV)." Transfusion Science 11 (January 1990): S3—S7. http://dx.doi.org/10.1016/0955-3886(90)90076-u.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Davis, Teaniese Latham, and Ralph DiClemente. "Human Immunodeficiency Virus Prevention." Child and Adolescent Psychiatric Clinics of North America 25, no. 2 (April 2016): 283–95. http://dx.doi.org/10.1016/j.chc.2015.11.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

TAIWO, BABAFEMI O., and CHARLES B. HICKS. "Primary Human Immunodeficiency Virus." Southern Medical Journal 95, no. 11 (November 2002): 1312–17. http://dx.doi.org/10.1097/00007611-200211000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

TAIWO, BABAFEMI O., and CHARLES B. HICKS. "Primary Human Immunodeficiency Virus." Southern Medical Journal 95, no. 11 (November 2002): 1312–17. http://dx.doi.org/10.1097/00007611-200295110-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Gallant, Joel E. "Human Immunodeficiency Virus Medicine." Journal of Infectious Diseases 216, suppl_5 (September 15, 2017): S624—S625. http://dx.doi.org/10.1093/infdis/jix238.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Goepfert, Paul, and Anju Bansal. "Human Immunodeficiency Virus Vaccines." Infectious Disease Clinics of North America 28, no. 4 (December 2014): 615–31. http://dx.doi.org/10.1016/j.idc.2014.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Phair, J. P. "Human immunodeficiency virus antigenemia." JAMA: The Journal of the American Medical Association 258, no. 9 (September 4, 1987): 1218. http://dx.doi.org/10.1001/jama.258.9.1218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Phair, John P. "Human Immunodeficiency Virus Antigenemia." JAMA: The Journal of the American Medical Association 258, no. 9 (September 4, 1987): 1218. http://dx.doi.org/10.1001/jama.1987.03400090102044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Hulsebosch, Hendrik J., Frans A. P. Claessen, Cornelis J. W. van Ginkel, Guus R. R. Kuiters, Jaap Goudsmit, and Joep M. A. Lange. "Human immunodeficiency virus exanthem." Journal of the American Academy of Dermatology 23, no. 3 (September 1990): 483–86. http://dx.doi.org/10.1016/0190-9622(90)70245-d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Strauss, Jose, Gaston Zilleruelo, Carolyn Abitbol, Brenda Montane, and Victoriano Pardo. "Human immunodeficiency virus nephropathy." Pediatric Nephrology 7, no. 2 (April 1993): 220–25. http://dx.doi.org/10.1007/bf00864411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Human immunodeficiency virus' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography